NCBiotech Directory


Issue link:

Contents of this Issue


Page 13 of 39

ChemoGenics Biopharma LLC (Research Triangle Park) provides drug discovery research services such as medicinal chemistry, DMPK, bioinformatics and preclinical models in cancer, inf ammation and metabolic diseases. ChemQ Bioscience LLC (Research Triangle Park) develops new liquid-based cytology processing products that help prepare specimens for unobstructed clear analysis of cells by pathologists. Chem-Tex Laboratories Inc. (Concord) develops and manufactures specialty chemicals for the textiles, paper and industrial polymer industries. Its product Bac-Shield contains a natural microbial extracted from snow crab shells. Chemtura USA (Gastonia) manufactures specialty chemicals and crop protection products. Chesson Laboratory Associates Inc. (Durham) develops polymer-based medical products. Chiesi USA Inc. (Cary) is a specialty pharmaceutical company focused on commercializing products for the hospital and adjacent specialty markets. Chiltern International Inc. (Wilmington and Cary) conducts phase one through four global clinical trials across a broad range of therapeutic areas, functional service provision and contract staf ng solutions. Chimerix Inc. (Durham) develops oral antiviral therapeutics for viral diseases including adenoviruses, CMV, BK virus, HPV, HIV and HCV. Chirazyme Labs Inc. (Greenville) produces enzymes for stereospecif c epoxidation intermediates in pharmaceutical synthesis. Cirrus, a Kemwell company (Morrisville) provides product development services, including physical and chemical characterization, formulation development, stability testing, process development, as well as scale-up and technical transfer to manufacturing. CivaTech Oncology Inc. (Research Triangle Park) develops radioactive polymer-based devices to treat localized tumors. CiVentiChem (Cary) provides contract R&D services, medicinal chemistry, lead optimization, process R&D, cGMP Synthesis of APIs for clinical trials, cGMP/GLP analytical services, CMC consulting and custom synthesis of pharmaceutical intermediates and APIs. Clavé Biodesign Inc. (Cary) develops cell-specif c peptides which can be used for therapeutic purposes related to cancer, cardiovascular disease and ophthalmology as well as for diagnostic imaging and biomarkers. Clearside Biomedical Inc. (Durham) develops f rst-in-class drug therapies to treat chronic, blinding diseases of the eye. Clinical Sensors Inc. (Durham) is developing membrane technologies for point-of-care sensors that enable early detection and monitoring of critical diseases and conditions. Clinical Sensors is focused on both implantable devices and point-of-care diagnostics. Cloud Pharmaceuticals Inc. (Research Triangle Park) uses high-performance computing and the principles of personalized medicine to enable clients and partners to speed drug development, especially in oncology. Cmed Clinical Services (Durham) provides clinical services to drug development organizations and manages early-phase studies (phase one through two b) with a focus in oncology, infectious disease, respiratory infection and cardiology. NCBIOTECH CENTER Companies Ch – Cr North Carolina Bioscience Companies 12

Articles in this issue

Links on this page

Archives of this issue

view archives of NCBiotech Directory - 2015